Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey Beckman who wrote (263)	10/5/1999 12:46:00 PM
From: Paul K	Respond to of 288

Haven't seen any rumors. Some institution has been trying to sell 100-200k every day for the past month. I'm waiting for it to bottom, maybe 11 some time this month to get a few more shares. Seems to be the pattern every fall <pun>

To: Jeffrey Beckman who wrote (263)	10/5/1999 1:48:00 PM
From: WallStBum	Respond to of 288

Nothing here Jeff. I'm going on recent news, the chart and gut.

To: Jeffrey Beckman who wrote (263)	10/7/1999 12:44:00 PM
From: WallStBum	Read Replies (1) \| Respond to of 288

Thursday October 7, 10:26 am Eastern Time M.H. Meyerson & Co., Inc. Restarts Coverage of Colorado MEDTech, Inc. (Nasdaq: CMED) with a 'Buy' Rating JERSEY CITY, N.J., Oct. 7 /PRNewswire/ -- The following is being issued by M.H. Meyerson & Co., Inc., a member of the National Association of Securities Dealers, CRD number 540: M.H. Meyerson & Co., Inc., (Nasdaq: MHMY - news) announced coverage has been restarted on Colorado MEDTech, Inc. (Nasdaq: CMED - news), with a ``BUY' rating. A Research Brief is available. The report was prepared by Andrew H. Scott of M.H. Meyerson & Co., Inc., 525 Washington Blvd., Jersey City, New Jersey 07310. For more information, contact Andrew H. Scott at 201-459-9440 or 800-422-4114; web site: mhmeyerson.com. SOURCE: M.H. Meyerson & Co., Inc.